Anti-IL-6 chimeric monoclonal antibody
From Wikipedia, the free encyclopedia
Anti-IL-6 chimeric monoclonal antibody is a chimeric (made from human and mouse proteins) monoclonal antibody being studied in the treatment of advanced kidney cancer and other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Anti-IL-6 chimeric monoclonal antibody works by blocking inflammation and tumor growth. Also called CNTO 328 and cCLB8.
[edit] External links
- Anti-IL-6 chimeric monoclonal antibody entry in the public domain NCI Dictionary of Cancer Terms
This article includes text from the U.S. National Cancer Institute's public domain Dictionary of Cancer Terms
 |
This oncology article is a stub. You can help Wikipedia by expanding it. |
